1. Home
  2. GLOB vs GKOS Comparison

GLOB vs GKOS Comparison

Compare GLOB & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLOB
  • GKOS
  • Stock Information
  • Founded
  • GLOB 2003
  • GKOS 1998
  • Country
  • GLOB Luxembourg
  • GKOS United States
  • Employees
  • GLOB N/A
  • GKOS N/A
  • Industry
  • GLOB EDP Services
  • GKOS Medical/Dental Instruments
  • Sector
  • GLOB Technology
  • GKOS Health Care
  • Exchange
  • GLOB Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • GLOB 4.7B
  • GKOS 5.4B
  • IPO Year
  • GLOB 2014
  • GKOS 2015
  • Fundamental
  • Price
  • GLOB $59.46
  • GKOS $77.09
  • Analyst Decision
  • GLOB Buy
  • GKOS Strong Buy
  • Analyst Count
  • GLOB 15
  • GKOS 13
  • Target Price
  • GLOB $131.20
  • GKOS $122.54
  • AVG Volume (30 Days)
  • GLOB 1.3M
  • GKOS 1.3M
  • Earning Date
  • GLOB 11-13-2025
  • GKOS 10-29-2025
  • Dividend Yield
  • GLOB N/A
  • GKOS N/A
  • EPS Growth
  • GLOB N/A
  • GKOS N/A
  • EPS
  • GLOB 2.44
  • GKOS N/A
  • Revenue
  • GLOB $2,482,415,000.00
  • GKOS $432,953,000.00
  • Revenue This Year
  • GLOB $3.49
  • GKOS $28.90
  • Revenue Next Year
  • GLOB $2.28
  • GKOS $25.48
  • P/E Ratio
  • GLOB $24.33
  • GKOS N/A
  • Revenue Growth
  • GLOB 8.66
  • GKOS 26.70
  • 52 Week Low
  • GLOB $54.36
  • GKOS $73.16
  • 52 Week High
  • GLOB $238.32
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • GLOB 48.37
  • GKOS 39.99
  • Support Level
  • GLOB $58.56
  • GKOS $73.16
  • Resistance Level
  • GLOB $64.19
  • GKOS $79.50
  • Average True Range (ATR)
  • GLOB 2.65
  • GKOS 4.40
  • MACD
  • GLOB 0.45
  • GKOS -0.49
  • Stochastic Oscillator
  • GLOB 41.57
  • GKOS 23.69

About GLOB Globant S.A.

Globant is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the US and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: